149 related articles for article (PubMed ID: 8095622)
1. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.
Valero MV; Amador LR; Galindo C; Figueroa J; Bello MS; Murillo LA; Mora AL; Patarroyo G; Rocha CL; Rojas M
Lancet; 1993 Mar; 341(8847):705-10. PubMed ID: 8095622
[TBL] [Abstract][Full Text] [Related]
2. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
[TBL] [Abstract][Full Text] [Related]
6. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.
Valero MV; Amador R; Aponte JJ; Narvaez A; Galindo C; Silva Y; Rosas J; Guzman F; Patarroyo ME
Vaccine; 1996 Oct; 14(15):1466-70. PubMed ID: 8994323
[TBL] [Abstract][Full Text] [Related]
8. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador.
Sempértegui F; Estrella B; Moscoso J; Piedrahita L; Hernández D; Gaybor J; Naranjo P; Mancero O; Arias S; Bernal R
Vaccine; 1994 Mar; 12(4):337-42. PubMed ID: 8178556
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato River region.
Lopera TM; Restrepo M; Blair S; García HI
Mem Inst Oswaldo Cruz; 1998; 93(4):495-500. PubMed ID: 9711340
[TBL] [Abstract][Full Text] [Related]
10. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
[TBL] [Abstract][Full Text] [Related]
12. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.
Alonso PL; Tanner M; Smith T; Hayes RJ; Schellenberg JA; Lopez MC; Bastos de Azevedo I; Menendez C; Lyimo E; Weiss N
Vaccine; 1994 Feb; 12(2):181-6. PubMed ID: 8147101
[TBL] [Abstract][Full Text] [Related]
13. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission.
Teuscher T; Schellenberg JR; Bastos de Azevedo I; Hurt N; Smith T; Hayes R; Masanja H; Silva Y; Lopez MC; Kitua A
Vaccine; 1994 Mar; 12(4):328-36. PubMed ID: 8178555
[TBL] [Abstract][Full Text] [Related]
14. The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity.
Amador R; Moreno A; Valero V; Murillo L; Mora AL; Rojas M; Rocha C; Salcedo M; Guzman F; Espejo F
Vaccine; 1992; 10(3):179-84. PubMed ID: 1557934
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Vaccines for preventing malaria.
Graves P; Gelband H
Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
[TBL] [Abstract][Full Text] [Related]
16. Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years.
Patarroyo G; Franco L; Amador R; Murillo LA; Rocha CL; Rojas M; Patarroyo ME
Vaccine; 1992; 10(3):175-8. PubMed ID: 1557933
[TBL] [Abstract][Full Text] [Related]
17. The development of malaria vaccines: SPf66--what next?
Tanner M; Alonso PL
Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.
Amador R; Moreno A; Murillo LA; Sierra O; Saavedra D; Rojas M; Mora AL; Rocha CL; Alvarado F; Falla JC
J Infect Dis; 1992 Jul; 166(1):139-44. PubMed ID: 1607685
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
Acosta CJ; Galindo CM; Schellenberg D; Aponte JJ; Kahigwa E; Urassa H; Schellenberg JR; Masanja H; Hayes R; Kitua AY; Lwilla F; Mshinda H; Menendez C; Tanner M; Alonso PL
Trop Med Int Health; 1999 May; 4(5):368-76. PubMed ID: 10402973
[TBL] [Abstract][Full Text] [Related]
20. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
Alonso PL; Smith TA; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Hayes R; Hurt N; Font F; Menendez C; Kilama WL; Tanner M
J Infect Dis; 1996 Aug; 174(2):367-72. PubMed ID: 8699068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
